NCT05784701View on ClinicalTrials.gov

Trivalent Salmonella Conjugate Vaccine (TSCV)

PHASE2RecruitingINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

April 5, 2023

Primary Completion Date

January 5, 2027

Study Completion Date

December 30, 2027

Conditions
Trivalent Salmonella Conjugate Vaccine (TSCV)
Interventions
DRUG

TSCV (Full-strength)

TSCV (Full-strength)

DRUG

TSCV (Half-strength)

TSCV (Half-strength)

DRUG

Typbar-TCV

Typbar-TCV

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

RECRUITING

Centre for Vaccine Development (CVD-Mali), Bamako

Sponsors
All Listed Sponsors
collaborator

Bharat Biotech International

UNKNOWN

collaborator

Wellcome Trust

OTHER

lead

University of Maryland, Baltimore

OTHER